Progress, science and the continental wins that rarely reach the wires.
Cairo-based Reme-D has raised $1.45M to scale heat-stable molecular diagnostic kits that need no refrigerated cold chain, a fix aimed squarely at the infrastructure gap that delays disease detection across Africa.
After losing a family member to a fundraising campaign that came together too late, a Port Harcourt founder built a healthtech startup that verifies every medical fundraiser through a partner hospital before it can accept a naira.
WeLight, the largest solar mini-grid operator in Africa, is raising $650m to grow its customer base tenfold to one million connections by 2030 — and it's aiming straight at Nigeria and DR Congo, home to the world's two biggest electricity-access gaps.
IMPALA, a Malawian-developed bedside monitor that uses machine learning to flag a child's decline up to three hours early, has cut deaths by 40–51% at two hospitals — and is now running on more than 800 monitors across six African countries.
Mission 300, the World Bank and African Development Bank drive to end energy poverty, has connected more than 50 million people across 40 countries and is now electrifying Africa at nearly double its starting speed. Tanzania alone added 7.5 million. The real story is the flywheel behind the number.
Gavi will make the first cash disbursements from its $1.2 billion African Vaccine Manufacturing Accelerator to an African manufacturer in the second half of 2026 — the moment a decade-long push to end the continent's dependence on imported vaccines turns from blueprint into balance sheet.
From drone-delivered blood in Rwanda to mRNA vaccine plants in Egypt and South Africa, African health innovation is quietly rewriting what's possible — and saving lives at scale.
